1.9182
price up icon0.43%   0.0082
pre-market  Vorhandelsmarkt:  1.98   0.0618   +3.22%
loading

Medicinova Inc Aktie (MNOV) Neueste Nachrichten

pulisher
Feb 03, 2025

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat

Feb 03, 2025
pulisher
Jan 28, 2025

US Exchange Penny Stocks To Watch In January 2025 - Yahoo Finance

Jan 28, 2025
pulisher
Jan 26, 2025

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - Defense World

Jan 26, 2025
pulisher
Jan 26, 2025

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - MarketBeat

Jan 26, 2025
pulisher
Jan 18, 2025

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Jane Street Group LLC Takes $30,000 Position in MediciNova, Inc. (NASDAQ:MNOV) - Defense World

Jan 17, 2025
pulisher
Jan 10, 2025

MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

MediciNova, Inc. (NASDAQ:MNOV) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - Defense World

Jan 10, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 02, 2025
pulisher
Dec 17, 2024

MediciNova (NASDAQ:MNOV) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Dec 17, 2024
pulisher
Dec 12, 2024

MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial… - MSN

Dec 12, 2024
pulisher
Dec 09, 2024

MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial - Smartkarma

Dec 09, 2024
pulisher
Dec 06, 2024

Drug Trial Shows Positive Interim Results for ALS Treatment - Streetwise Reports

Dec 06, 2024
pulisher
Dec 05, 2024

MediciNova Presents Study Update and Interim Analysis of - GlobeNewswire

Dec 05, 2024
pulisher
Dec 05, 2024

MediciNova Reports Strong Interim Data from ALS Drug Trial, Shows Promising Correlations - StockTitan

Dec 05, 2024
pulisher
Dec 03, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at D. Boral Capital - Defense World

Dec 03, 2024
pulisher
Dec 02, 2024

MediciNova stock undervalued? D. Boral sees upside in ALS & MS market opportunities - Investing.com India

Dec 02, 2024
pulisher
Dec 02, 2024

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 02, 2024
pulisher
Nov 29, 2024

Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute - Kursiv Media

Nov 29, 2024
pulisher
Nov 26, 2024

MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement - Smartkarma

Nov 26, 2024
pulisher
Nov 25, 2024

MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement… - MSN

Nov 25, 2024
pulisher
Nov 21, 2024

MediciNova, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024
pulisher
Nov 19, 2024

MediciNova reports progress in ALS and Long COVID trials - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova Partners with NIH for ALS Trial, Reports $42.3M Cash Position | MNOV Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver - The Manila Times

Nov 15, 2024
pulisher
Nov 14, 2024

MediciNova Receives Notice of Allowance from United States - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova: Q3 Earnings Snapshot - Darien Times

Nov 14, 2024
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Kapitalisierung:     |  Volumen (24h):